ElisabettaE.PaceElisabettaE. i inni, Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action, „Pharmaceutics”, 14 (6), 2022, s. 1261, DOI: 10.3390/pharmaceutics14061261, PMID: 35745833, PMCID: PMC9227620 [dostęp 2023-09-30].
Jin-PingJ.P.ZhengJin-PingJ.P. i inni, Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study, „The Lancet”, 371 (9629), 2008, s. 2013–2018, DOI: 10.1016/S0140-6736(08)60869-7, PMID: 18555912.
PaulineP.MalletPaulineP. i inni, Respiratory Paradoxical Adverse Drug Reactions Associated with Acetylcysteine and Carbocysteine Systemic Use in Paediatric Patients: A National Survey, „PLoS ONE”, 6 (7), 2011, DOI: 10.1371/journal.pone.0022792, PMID: 21818391, PMCID: PMC3144941.
YuichiY.MajimaYuichiY. i inni, Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp, „Auris, Nasus, Larynx”, 39 (1), 2012, s. 38–47, DOI: 10.1016/j.anl.2011.04.015, PMID: 21636230.
R.H.R.H.WaringR.H.R.H., S.C.S.C.MitchellS.C.S.C., The metabolism and elimination of S-carboxymethyl-L-cysteine in man, „Drug Metabolism and Disposition: The Biological Fate of Chemicals”, 10 (1), 1982, s. 61–62, PMID: 6124385 [dostęp 2023-09-30].
ElisabettaE.PaceElisabettaE. i inni, Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action, „Pharmaceutics”, 14 (6), 2022, s. 1261, DOI: 10.3390/pharmaceutics14061261, PMID: 35745833, PMCID: PMC9227620 [dostęp 2023-09-30].
Jin-PingJ.P.ZhengJin-PingJ.P. i inni, Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study, „The Lancet”, 371 (9629), 2008, s. 2013–2018, DOI: 10.1016/S0140-6736(08)60869-7, PMID: 18555912.
PaulineP.MalletPaulineP. i inni, Respiratory Paradoxical Adverse Drug Reactions Associated with Acetylcysteine and Carbocysteine Systemic Use in Paediatric Patients: A National Survey, „PLoS ONE”, 6 (7), 2011, DOI: 10.1371/journal.pone.0022792, PMID: 21818391, PMCID: PMC3144941.
YoshihisaY.IshiuraYoshihisaY. i inni, Effect of carbocysteine on cough reflex to capsaicin in asthmatic patients, „British Journal of Clinical Pharmacology”, 55 (6), 2003, s. 504–510, PMID: 12814442, PMCID: PMC1884258.
C.C.AstiC.C. i inni, Effectiveness of carbocysteine lysine salt monohydrate on models of airway inflammation and hyperresponsiveness, „Pharmacological Research”, 31 (6), 1995, s. 387–392, PMID: 8685078.
YuichiY.MajimaYuichiY. i inni, Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp, „Auris, Nasus, Larynx”, 39 (1), 2012, s. 38–47, DOI: 10.1016/j.anl.2011.04.015, PMID: 21636230.
